Abilify MyCite for treating bipolar disorder 1 or schizophrenia [ID3833]

Status:

Topic selection

Decision:

Awaiting decision

ID number:

3833

Timeline

Key events during the development of the guidance:

For further information on how we select topics for development, please see our page about prioritising our guidance topics